The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis.
Clin Chem Lab Med
; 59(11): e405-e408, 2021 10 26.
Article
en En
| MEDLINE
| ID: mdl-34187132
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Trombosis
/
Factor Plaquetario 4
/
Heparina
/
SARS-CoV-2
/
Tratamiento Farmacológico de COVID-19
/
Anticuerpos
Tipo de estudio:
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2021
Tipo del documento:
Article